Jazz Pharmaceuticals Net Profit Margin 2007-2020 | JAZZ

Current and historical net profit margin for Jazz Pharmaceuticals (JAZZ) from 2007 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue. Jazz Pharmaceuticals net profit margin for the three months ending June 30, 2020 was .
Jazz Pharmaceuticals Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2020-06-30 $2.22B $0.13B 6.00%
2020-03-31 $2.19B $0.28B 12.79%
2019-12-31 $2.16B $0.52B 24.19%
2019-09-30 $2.06B $0.61B 29.57%
2019-06-30 $1.99B $0.66B 32.96%
2019-03-31 $1.95B $0.49B 24.83%
2018-12-31 $1.89B $0.45B 23.60%
2018-09-30 $1.85B $0.52B 28.05%
2018-06-30 $1.79B $0.43B 24.21%
2018-03-31 $1.69B $0.45B 26.56%
2017-12-31 $1.62B $0.49B 30.22%
2017-09-30 $1.58B $0.37B 23.69%
2017-06-30 $1.54B $0.40B 25.96%
2017-03-31 $1.53B $0.41B 26.77%
2016-12-31 $1.49B $0.40B 26.75%
2016-09-30 $1.43B $0.36B 25.42%
2016-06-30 $1.40B $0.36B 25.88%
2016-03-31 $1.35B $0.34B 24.78%
2015-12-31 $1.33B $0.33B 24.91%
2015-09-30 $1.31B $0.33B 25.08%
2015-06-30 $1.28B $0.27B 20.89%
2015-03-31 $1.24B $0.22B 18.06%
2014-12-31 $1.17B $0.06B 5.03%
2014-09-30 $1.08B $0.03B 2.96%
2014-06-30 $1.01B $0.08B 8.05%
2014-03-31 $0.92B $0.08B 8.56%
2013-12-31 $0.87B $0.22B 24.66%
2013-09-30 $0.82B $0.36B 44.02%
2013-06-30 $0.76B $0.32B 41.75%
2013-03-31 $0.68B $0.30B 44.71%
2012-12-31 $0.59B $0.29B 49.23%
2012-09-30 $0.49B $0.13B 25.67%
2012-06-30 $0.38B $0.12B 32.29%
2012-03-31 $0.33B $0.13B 40.00%
2011-12-31 $0.27B $0.12B 45.42%
2011-09-30 $0.24B $0.11B 45.87%
2011-06-30 $0.21B $0.09B 42.99%
2011-03-31 $0.19B $0.05B 28.04%
2010-12-31 $0.17B $0.03B 18.50%
2010-09-30 $0.16B $0.01B 8.86%
2010-06-30 $0.14B $-0.00B -0.69%
2010-03-31 $0.14B $0.01B 4.96%
2009-12-31 $0.13B $-0.01B -5.47%
2009-09-30 $0.11B $-0.07B -63.64%
2009-06-30 $0.10B $-0.10B -100.00%
2009-03-31 $0.08B $-0.15B -198.68%
2008-12-31 $0.07B $-0.19B -268.12%
2008-09-30 $0.06B $-0.19B -293.75%
2008-06-30 $0.07B $-0.18B -265.67%
2008-03-31 $0.07B $-0.17B -255.38%
2007-12-31 $0.06B $-0.14B -217.19%
2007-06-30 $0.04B $-0.05B -133.33%
2007-03-31 $0.04B $-0.04B -100.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $8.333B $2.162B
Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Company's goal is to build a broad portfolio of products through a combination of internal development and acquisition/in-licensing activities and to utilize our specialty sales force to promote products in our target markets. They apply novel formulations and drug delivery technologies to known drug compounds, and compounds with the same mechanism of action or similar chemical structure as marketed products, to improve patient care by improving efficacy, reducing adverse side effects or increasing patient compliance relative to existing therapies. Based in Palo Alto, California, the company is committed to working closely with patients, patient advocacy groups and healthcare professionals.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.681B 44.19
Takeda Pharmaceutical (TAK) Japan $52.525B 9.15
Astellas Pharma (ALPMY) Japan $26.270B 0.00
Eisai (ESALY) Japan $23.622B 19.96
UCB SA (UCBJF) Belgium $21.561B 0.00
Merck (MKGAF) Germany $20.091B 0.00
Ono Pharmaceutical (OPHLF) Japan $15.938B 28.18
Catalent (CTLT) United States $15.467B 50.28
Grifols, S.A (GRFS) Spain $12.727B 15.56
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.683B 25.17
Neurocrine Biosciences (NBIX) United States $9.233B 35.74
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.221B 0.00
IPSEN SA ADR (IPSEY) France $7.439B 0.00
STADA ARZNEIMI (STDAF) Germany $7.169B 0.00
Ionis Pharmaceuticals (IONS) United States $6.613B 41.89
Orion OYJ (ORINY) Finland $6.272B 21.76
Arrowhead Pharmaceuticals (ARWR) United States $6.023B 0.00
United Therapeutics (UTHR) United States $5.453B 12.61
Evotec AG (EVTCY) Germany $4.517B 145.40
ChemoCentryx (CCXI) United States $4.051B 0.00
FibroGen (FGEN) United States $3.849B 0.00
Sage Therapeutics (SAGE) United States $3.717B 0.00
PTC Therapeutics (PTCT) United States $3.518B 0.00
Hypermarcas (HYPMY) Brazil $3.483B 12.81
Nektar Therapeutics (NKTR) United States $3.138B 0.00
Revolution Medicines (RVMD) United States $2.661B 0.00
Pacira BioSciences (PCRX) United States $2.371B 62.33
Taro Pharmaceutical Industries (TARO) Israel $2.295B 11.11
Xencor (XNCR) United States $2.260B 0.00
Corcept Therapeutics (CORT) United States $2.063B 18.99
Cronos Group (CRON) Canada $2.040B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.980B 0.00
USANA Health Sciences (USNA) United States $1.805B 15.90
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.561B 14.89
Ironwood Pharmaceuticals (IRWD) United States $1.542B 10.71
Heron Therapeutics (HRTX) United States $1.499B 0.00
Endo (ENDP) Ireland $1.331B 1.97
Trillium Therapeutics (TRIL) Canada $1.277B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.244B 0.00
Zogenix (ZGNX) United States $1.180B 0.00
Karyopharm Therapeutics (KPTI) United States $1.158B 0.00
Translate Bio (TBIO) United States $1.042B 0.00
Indivior (INVVY) United States $1.030B 12.77
CLINIGEN GP (CLIGF) United Kingdom $1.028B 0.00
ImmunoGen (IMGN) United States $0.953B 0.00
Esperion Therapeutics (ESPR) United States $0.899B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.880B 548.13
Tilray (TLRY) Canada $0.856B 0.00
Vectura Group (VEGPF) United Kingdom $0.795B 0.00
Ocular Therapeutix (OCUL) United States $0.726B 0.00
Collegium Pharmaceutical (COLL) United States $0.668B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.655B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.648B 32.29
Radius Health (RDUS) United States $0.640B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.623B 0.00
VAXART, INC (VXRT) United States $0.617B 0.00
Flexion Therapeutics (FLXN) United States $0.601B 0.00
Siga Technologies (SIGA) United States $0.533B 56.83
Spectrum Pharmaceuticals (SPPI) United States $0.495B 0.00
Molecular Templates (MTEM) United States $0.483B 0.00
Aerie Pharmaceuticals (AERI) United States $0.461B 0.00
Ardelyx (ARDX) United States $0.460B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.458B 0.00
Akebia Therapeutics (AKBA) United States $0.456B 0.00
Organogenesis Holdings (ORGO) United States $0.444B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.416B 0.00
TherapeuticsMD (TXMD) United States $0.403B 0.00
Altimmune (ALT) United States $0.395B 0.00
DURECT (DRRX) United States $0.387B 0.00
Harpoon Therapeutics (HARP) United States $0.386B 0.00
Redhill Biopharma (RDHL) Israel $0.362B 0.00
Concert Pharmaceuticals (CNCE) United States $0.353B 0.00
Profound Medical (PROF) Canada $0.342B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.330B 8.18
Jounce Therapeutics (JNCE) United States $0.323B 15.31
Innate Pharma SA (IPHYF) France $0.323B 0.00
MEI Pharma (MEIP) United States $0.321B 0.00
Menlo Therapeutics (VYNE) United States $0.315B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.311B 0.00
Lannett Co Inc (LCI) United States $0.282B 6.55
KalVista Pharmaceuticals (KALV) United States $0.273B 0.00
Rafael Holdings (RFL) United States $0.268B 0.00
Calithera Biosciences (CALA) United States $0.258B 0.00
CTI BioPharma (CTIC) United States $0.258B 0.00
Xeris Pharmaceuticals (XERS) United States $0.257B 0.00
Aduro Biotech (KDNY) United States $0.250B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.242B 0.00
IMV INC (IMV) Canada $0.227B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.220B 0.00
CASI Pharmaceuticals (CASI) United States $0.219B 0.00
Nature's Sunshine Products (NATR) United States $0.214B 21.14
Nivalis Therapeutics (ALPN) United States $0.187B 0.00
Aclaris Therapeutics (ACRS) United States $0.184B 0.00
Otonomy (OTIC) United States $0.183B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.178B 0.00
Aquestive Therapeutics (AQST) United States $0.177B 0.00
Heat Biologics (HTBX) United States $0.177B 0.00
Taiwan Liposome (TLC) Taiwan $0.174B 0.00
OptiNose (OPTN) United States $0.173B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.173B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.159B 0.00
Champions Oncology (CSBR) United States $0.113B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.112B 0.00
ProPhase Labs (PRPH) United States $0.104B 0.00
MediWound (MDWD) Israel $0.096B 0.00
Lipocine (LPCN) United States $0.090B 0.00
Hemispherx BioPharma (AIM) United States $0.083B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.083B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.077B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.076B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.075B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.074B 0.00
ElectroCore (ECOR) United States $0.074B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.071B 0.00
Novan (NOVN) United States $0.070B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.070B 0.00
Infinity Pharmaceuticals (INFI) United States $0.069B 0.00
Addex Therapeutics (ADXN) Switzerland $0.068B 0.00
Biomerica (BMRA) United States $0.066B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.063B 0.00
AgeX Therapeutics (AGE) United States $0.063B 0.00
SCYNEXIS (SCYX) United States $0.054B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.052B 0.00
India Globalization Capital (IGC) United States $0.051B 0.00
Natural Alternatives (NAII) United States $0.051B 0.00
Onconova Therapeutics (ONTX) United States $0.051B 0.00
Recro Pharma (REPH) United States $0.046B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.045B 27.32
Forward Pharma (FWP) Denmark $0.045B 0.00
Neos Therapeutics (NEOS) United States $0.039B 0.00
PolarityTE (PTE) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.035B 8.93
GTx (ONCT) United States $0.033B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.032B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.031B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.030B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.030B 0.00
Can-Fite Biopharma (CANF) Israel $0.027B 0.00
Midatech Pharma (MTP) United Kingdom $0.026B 0.00
IsoRay (ISR) United States $0.025B 0.00
Jaguar Animal Health (JAGX) United States $0.021B 0.00
Regulus Therapeutics (RGLS) United States $0.020B 0.00
Sundial Growers (SNDL) Canada $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Bio-Path Holdings (BPTH) United States $0.017B 0.00
Cyanotech (CYAN) United States $0.017B 25.64
Vical (BBI) United States $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.016B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Hancock Jaffe Laboratories (HJLI) United States $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.012B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Iterum Therapeutics (ITRM) Ireland $0.011B 0.00
JanOne (JAN) United States $0.009B 0.00
Shineco (TYHT) China $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00